Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Alcoholic Hepatitis Treatment Market: By Type: Corticosteroids, Xanthine Derivatives, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand; Competitive Landscape; Industry Events and Developments
Global Alcoholic Hepatitis Treatment Market Outlook
The global alcoholic hepatitis treatment market size will grow at a CAGR of 7% during the forecast period of 2022-2027. Globally, rising alcohol consumption has led to the alcoholic hepatitis treatment market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Alcoholic hepatitis is induced by heavy alcohol intake, leading to hepatic encephalopathy. Such levels of alcohol consumption have resulted in high mortality rates. As a result, alcoholic hepatitis needs to be treated dynamically. Vendors use this platform to sell other treatment options as well. There are several off-label drugs and corticosteroids in the market. Off-label treatments are used as a first-line treatment for alcoholic hepatitis inflammation and corticosteroids. Due to the lack of curative medicines available in the industry, the demand for these medications is expected to increase.
Properties and Applications
Alcoholic hepatitis is caused by the excessive intake of alcohol, also known as hepatitis, inflammation of the liver. It is usually found in combination with fatty liver, an early stage of alcoholic liver disease, and can contribute to fibrosis development, leading to cirrhosis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The alcoholic hepatitis treatment market can be divided on the basis of segments like types and regions.
The industry can be broadly categorised on the basis of type into:
- Corticosteroids
- Xanthine Derivatives
- Others
The EMR report looks into the regional markets for alcoholic hepatitis treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The main factors resulting in the growth of the global hepatitis treatment market is the development of new strategies and viable treatment options for alcoholic hepatitis management. Presently, there are no effective treatments available for serious alcoholic hepatitis, and this condition is being capitalized by vendors. In the forthcoming years, there will be tremendous growth potential for vendors. Vendors focus on the development of innovative therapies as they prove to be highly effective. Several experimental drugs are undergoing clinical trials, which during the forecast period, will have a positive impact on the industry growth for hepatitis treatment.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global alcoholic hepatitis treatment market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Apotex Inc.
- Gilead Sciences Inc. (NASDAQ: GILD)
- Johnson & Johnson Services Inc.
- Novartis International AG
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Region |
| Breakup by Type | Corticosteroids, Xanthine Derivatives, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Apotex Inc., Gilead Sciences Inc. (GILD (NASDAQ)), Johnson & Johnson Services Inc. (JNJ (NYSE)), Novartis International AG (NOVN (SWX)), Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Alcoholic Hepatitis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Alcoholic Hepatitis Treatment Historical Market (2017-2021)
8.3 Global Alcoholic Hepatitis Treatment Market Forecast (2022-2027)
8.4 Global Alcoholic Hepatitis Treatment Market by Type
8.4.1 Corticosteroids
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Xanthine Derivatives
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Others
8.5 Global Alcoholic Hepatitis Treatment Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Spain
9.2.3.6 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Sun Pharmaceutical Industries Limited
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Gilead Sciences, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Teva Pharmaceutical Industries Ltd.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Saneca Pharmaceuticals a.s.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Alcoholic Hepatitis Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Alcoholic Hepatitis Treatment Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Alcoholic Hepatitis Treatment Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Alcoholic Hepatitis Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
5. Global Alcoholic Hepatitis Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
6. North America Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
7. North America Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
8. Europe Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
9. Europe Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Asia Pacific Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
11. Asia Pacific Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Latin America Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
13. Latin America Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Middle East and Africa Alcoholic Hepatitis Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15. Middle East and Africa Alcoholic Hepatitis Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Global Alcoholic Hepatitis Treatment Market Structure
Key Questions Answered in the Report
The global alcoholic hepatitis treatment market is projected to grow at a CAGR of 7% between 2021 and 2026.
The major drivers of the industry, such as the shifting consumer preferences and increased consumption of alcohol, rising disposable incomes, growing availability of off-label drugs and corticosteroids, and the increased government investments in the development of the healthcare sector, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing focus on research and development activities by the major players and rapid technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Corticosteroids and xanthine derivatives, among others, are the leading alcoholic hepatitis treatment types in the industry.
The major players in the industry are Apotex Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., and Novartis International AG, among others.
Analyst Review
The global alcoholic hepatitis treatment market is being driven by the development of the medical sector and the growing incidences of alcoholic hepatitis across the globe. Aided by the increasing complexity of clinical trials and the growing R&D activities, the market is expected to witness a robust growth in the forecast period of 2022-2027, growing at a CAGR of 7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on types, the industry can be segmented into corticosteroids and xanthine derivatives, among others. The major regional markets for alcoholic hepatitis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Apotex Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., Novartis International AG, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global veterinary diagnostic imaging market is driven by the growing prevalence of health-related issues in animals. Aided by the increasing use of veterinary diagnostic imaging in research activi...
The global urinalysis market attained a value of about USD 1.9 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 6.8% to reach nearly USD 2.8 bil...
The global dengue testing market stood at a value of around USD 456.2 million in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 4.63% to reach USD 598.4 ...
The global clinical nutrition market attained a value of about USD 33.60 billion in 2020, driven by the rise in the prevalence of metabolic disorders. Aided by the high spending on healthcare and incr...
The global liquid biopsy market stood at a value of around USD 1,250 million in 2020. The market is further expected to grow at a CAGR of 22% in the forecast period of 2022-2027 to attain a value of U...
NEWSLETTER